JP2006518731A5 - - Google Patents

Download PDF

Info

Publication number
JP2006518731A5
JP2006518731A5 JP2006502681A JP2006502681A JP2006518731A5 JP 2006518731 A5 JP2006518731 A5 JP 2006518731A5 JP 2006502681 A JP2006502681 A JP 2006502681A JP 2006502681 A JP2006502681 A JP 2006502681A JP 2006518731 A5 JP2006518731 A5 JP 2006518731A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
heart failure
acceptable salt
benzazepine
severe heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006502681A
Other languages
English (en)
Japanese (ja)
Other versions
JP4771937B2 (ja
JP2006518731A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/002085 external-priority patent/WO2004073716A1/en
Publication of JP2006518731A publication Critical patent/JP2006518731A/ja
Publication of JP2006518731A5 publication Critical patent/JP2006518731A5/ja
Application granted granted Critical
Publication of JP4771937B2 publication Critical patent/JP4771937B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006502681A 2003-02-24 2004-02-23 重症心不全の治療方法およびその薬剤 Expired - Lifetime JP4771937B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24
US60/448,878 2003-02-24
PCT/JP2004/002085 WO2004073716A1 (en) 2003-02-24 2004-02-23 Method for treating severe heart failure and medicament therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011049403A Division JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Publications (3)

Publication Number Publication Date
JP2006518731A JP2006518731A (ja) 2006-08-17
JP2006518731A5 true JP2006518731A5 (https=) 2006-11-24
JP4771937B2 JP4771937B2 (ja) 2011-09-14

Family

ID=32908667

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006502681A Expired - Lifetime JP4771937B2 (ja) 2003-02-24 2004-02-23 重症心不全の治療方法およびその薬剤
JP2011049403A Pending JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011049403A Pending JP2011148806A (ja) 2003-02-24 2011-03-07 重症心不全の治療方法およびその薬剤

Country Status (23)

Country Link
US (2) US7423032B2 (https=)
EP (2) EP2000142A1 (https=)
JP (2) JP4771937B2 (https=)
KR (1) KR100706727B1 (https=)
CN (1) CN100577171C (https=)
AR (1) AR043259A1 (https=)
AT (1) ATE411803T1 (https=)
AU (2) AU2004212842B9 (https=)
BR (1) BRPI0405657A (https=)
CA (1) CA2493475A1 (https=)
CY (1) CY1108583T1 (https=)
DE (1) DE602004017283D1 (https=)
DK (1) DK1596868T3 (https=)
ES (1) ES2315640T3 (https=)
MX (1) MXPA05001623A (https=)
MY (1) MY143740A (https=)
NO (1) NO335369B1 (https=)
PL (2) PL404315A1 (https=)
PT (1) PT1596868E (https=)
RU (2) RU2346689C2 (https=)
SI (1) SI1596868T1 (https=)
TW (1) TWI322689B (https=)
WO (1) WO2004073716A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
DK1968990T3 (da) 2005-12-27 2015-04-27 Otsuka Pharma Co Ltd Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
PT2146721E (pt) * 2007-05-15 2013-07-18 Otsuka Pharma Co Ltd Métodos de utilização de antagonistas da vasopressina com agentes quimioterapeuticos de antraciclina para reduzir a cardiotoxicidade e/ou melhorar a sobrevivência
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CN103002833B (zh) 2010-05-25 2016-05-11 耶拿阀门科技公司 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2016150806A1 (en) 2015-03-20 2016-09-29 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
CN107530168B (zh) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
CN120152682A (zh) 2022-11-09 2025-06-13 耶拿阀门科技公司 用于顺序地部署可扩张植入物的导管系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DK0450097T3 (da) 1989-10-20 1996-05-20 Otsuka Pharma Co Ltd Benzoheterocykliske forbindelser
AU657424B2 (en) 1992-07-02 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な5−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
EP1253945B1 (en) 2000-01-26 2006-10-04 Astellas Pharma Inc. Ace inhibitor-vasopressin antagonist combinations
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
ES2288899T3 (es) * 2000-10-04 2008-02-01 Astellas Pharma Inc. Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar.
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Similar Documents

Publication Publication Date Title
JP2006518731A5 (https=)
RU2008133654A (ru) Способ и лекарственное средство для лечения тяжелой сердечной недостаточности
JP2004519469A5 (https=)
JP2010077141A5 (https=)
JP2009536176A5 (https=)
JP2009102342A5 (https=)
JP2004522714A5 (https=)
JP2006503850A5 (https=)
JP2010540519A5 (https=)
JP2019515884A5 (https=)
JP2009513713A5 (https=)
JP2010065060A (ja) 心不全処置のための複合治療
JP5362151B2 (ja) Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
CN110123771A (zh) 药物组合药物
JP2010514834A5 (https=)
CA2521182A1 (en) Composition for improving cognition and memory
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
US20050256131A1 (en) Pharmaceutical active substance combination and the use thereof
JP2019531286A5 (https=)
US20260102370A1 (en) Methods of treating obesity in responder and non-responder populations
CN101507726B (zh) 窦房结If电流抑制剂和β-阻滞剂的组合
CN101015556B (zh) 窦房结If电流抑制剂与钙抑制剂的组合以及含有它的药物组合物
JP2008543813A5 (https=)
JP2015515971A5 (https=)
JP2008133229A (ja) 医薬組成物